Gastric IgA in cystic fibrosis in relation to the migrating motor complex

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 8, 2001, Pages 843-848

  Hallberg, K ^a   Mattsson Rydberg, A ^a   Fandriks L ^a   Strandvik, B ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Duodenogastric reflux; Intestinal motility; Mucosal immune system; Pancreatic sufficiency; Secretory IgA

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DUODENOGASTRIC REFLUX; FEMALE; GENOTYPE; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; MANOMETRY; PATHOPHYSIOLOGY; PERFUSION; PRIORITY JOURNAL; PROTEIN TRANSPORT; STOMACH MOTILITY; STOMACH MUCOSA; SWEAT TEST;

EID: 0034957353     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750313379     Document Type: Article

References (38)

1. The cystic fibrosis transmembrane conductance regulator and its function in epithelial transport
2. Epithelial sodium channels in cystic fibrosis
3. Gastroesophageal reflux in patients with cystic fibrosis
4. Complications of gastroesophageal reflux in patients with cystic fibrosis
5. Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying
6. Gastric emptying time is faster in cystic fibrosis
7. Prolonged small-intestinal transit time in cystic fibrosis
8. Malabsorption of bile acids in children with cystic fibrosis
9. A migrating electric complex of canine small intestine
10. Mechanisms behind changes in gastric acid and bicarbonate outputs during the human interdigestive motility cycle
11. The pH/PCO2 method for continuous determination of human gastric acid and bicarbonate secretion. A validation study
12. Function of mucosal immunoglobulins
13. Intestinal IgA: Novel views on its function in the defence of the largest mucosal surface
14. Gastric output of IgA in man: Relation to migrating motility complexes and sham feeding
15. Relationship between interdigestive motility and secretion of immunoglobulin A in human proximal small intestine
16. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients
17. Gastric secretion in cystic fibrosis in relation to the migrating motor complex
18. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori infected subjects
19. Cyclic motor activity; migrating motor complex
20. Antibiotic therapy of pulmonary infections in cystic fibrosis
21. Variability of migrating motor complex in humans
22. The human gastrointestinal secretory immune system in health and disease
23. Pepsin hydrolysis of IgA-delineation of two populations of molecules
24. Human duodenogastric reflux, retroperistalsis, and MMC
25. Selective transport of IgA. Cellular and molecular aspects
26. Antibody diffusion in human cervical mucus
27. Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon
28. Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by 12 human epithelial cells
29. Immunological study of histologically non-involved jejunum during Crohn's disease: Evidence for reduced in vivo secretion of secretory IgA
30. Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease
31. Transepithelial transport of immunoglobulins
32. Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A
33. Small bowel mucosal dysfunction in patients with cystic fibrosis
34. Intestinal permeability in cystic fibrosis in relation to genotype
35. Intestinal bile acid malabsorption in cystic fibrosis
36. Deficiency of secretory Ig-A and intestinal malabsorption
37. Secretory component deficiency. A disorder of the IgA immune system
38. Secretory immunoglobulin A (sIgA) in parotid saliva of patients with cystic fibrosis